This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Danaher agrees to divest products where it competes directly with GE biopharma unit

By Brian Baker ( March 20, 2020, 21:02 GMT | Insight) -- Danaher agreed to divest 10 products in markets where the company competed head-to-head with General Electric’s biopharma business and where the market would have been left with just two significant players to solve the US Federal Trade Commission’s concerns with the companies’ merger.Danaher agreed to divest 10 products in markets where the company competed head-to-head with General Electric’s biopharma business and where the market would have been left with just two significant players to solve the US Federal Trade Commission’s concerns with the companies’ merger. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login